(Q54577559)

English

Distinct clinical features and outcomes in never-smokers with nonsmall cell lung cancer who harbor EGFR or KRAS mutations or ALK rearrangement.

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21720997%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Distinct clinical features and outcomes in never-smokers with nonsmall cell lung cancer who harbor EGFR or KRAS mutations or ALK rearrangement (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21720997%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

1 reference

based on heuristic

inferred from title

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21720997%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21720997%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21720997%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Byoung Chul Cho

13

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21720997%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

12

object named as

Joo Hang Kim

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21720997%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Kyung Young Chung

10

object named as

Kyung Young Chung

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21720997%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

11

object named as

Ross Soo

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21720997%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

author name string

Hye Ryun Kim

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21720997%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Jin-Haeng Chung

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21720997%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Young Joo Lee

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21720997%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Yun Kyoung Hong

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21720997%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Se Hoon Kim

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21720997%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Se Kyu Kim

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21720997%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

language of work or name

0 references

publication date

30 June 2011

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21720997%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21720997%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

118

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21720997%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21720997%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

729-739

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21720997%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Cancer statistics, 2009

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26311

21 January 2018

Impact of environmental tobacco smoke on the incidence of mutations in epidermal growth factor receptor gene in never-smoker patients with non-small-cell lung cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26311

21 January 2018

Incidence of lung cancer in a large cohort of non-smoking men from Sweden

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26311

21 January 2018

Lung cancer death rates in lifelong nonsmokers.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26311

21 January 2018

Lung cancer in never smokers: a review

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26311

21 January 2018

Worldwide epidemiological patterns of lung cancer in nonsmokers

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26311

21 January 2018

Lung cancer in never smokers--a different disease

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26311

21 January 2018

Lung cancer in never smokers: change of a mindset in the molecular era.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26311

21 January 2018

Somatic mutations of epidermal growth factor receptor signaling pathway in lung cancers

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26311

21 January 2018

Clinical and biological features associated with epidermal growth factor receptor gene mutations in lung cancers

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26311

21 January 2018

Clinicopathologic significance of the mutations of the epidermal growth factor receptor gene in patients with non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26311

21 January 2018

The impact of human EGFR kinase domain mutations on lung tumorigenesis and in vivo sensitivity to EGFR-targeted therapies

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26311

21 January 2018

Mutations and addiction to EGFR: the Achilles 'heal' of lung cancers?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26311

21 January 2018

EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26311

21 January 2018

Use of cigarette-smoking history to estimate the likelihood of mutations in epidermal growth factor receptor gene exons 19 and 21 in lung adenocarcinomas

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26311

21 January 2018

Gefitinib versus docetaxel in previously treated non-small-cell lung cancer (INTEREST): a randomised phase III trial.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26311

21 January 2018

Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26311

21 January 2018

Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26311

21 January 2018

EML4-ALK: honing in on a new target in non-small-cell lung cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26311

21 January 2018

EML4-ALK fusion gene and efficacy of an ALK kinase inhibitor in lung cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26311

21 January 2018

Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26311

21 January 2018

Clinical features and outcome of patients with non-small-cell lung cancer who harbor EML4-ALK

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26311

21 January 2018

Multiplex reverse transcription-PCR screening for EML4-ALK fusion transcripts.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26311

21 January 2018

EML4-ALK fusion lung cancer: a rare acquired event

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26311

21 January 2018

EML4-ALK fusion is linked to histological characteristics in a subset of lung cancers

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26311

21 January 2018

EML4-ALK fusion transcripts, but no NPM-, TPM3-, CLTC-, ATIC-, or TFG-ALK fusion transcripts, in non-small cell lung carcinomas

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26311

21 January 2018

EML4-ALK lung cancers are characterized by rare other mutations, a TTF-1 cell lineage, an acinar histology, and young onset.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26311

21 January 2018

EML4-ALK rearrangement in non-small cell lung cancer and non-tumor lung tissues

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26311

21 January 2018

Cigarette smoking and K-ras mutations in pancreas, lung and colorectal adenocarcinomas: etiopathogenic similarities, differences and paradoxes

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26311

21 January 2018

Frequency and distinctive spectrum of KRAS mutations in never smokers with lung adenocarcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26311

21 January 2018

KRAS mutations and primary resistance of lung adenocarcinomas to gefitinib or erlotinib

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26311

21 January 2018

Lung Adenocarcinoma From East Asian Never-Smokers Is a Disease Largely Defined by Targetable Oncogenic Mutant Kinases

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26311

21 January 2018

The 2004 World Health Organization classification of lung tumors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26311

21 January 2018

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26311

21 January 2018

Predictive and prognostic impact of epidermal growth factor receptor mutation in non-small-cell lung cancer patients treated with gefitinib

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26311

21 January 2018

Screening of anaplastic lymphoma kinase rearrangement by immunohistochemistry in non-small cell lung cancer: correlation with fluorescence in situ hybridization.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26311

21 January 2018

Somatic mutations affect key pathways in lung adenocarcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26311

21 January 2018

A rigorous and comprehensive validation: common genetic variations and lung cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26311

21 January 2018

Role of 5p15.33 (TERT-CLPTM1L), 6p21.33 and 15q25.1 (CHRNA5-CHRNA3) variation and lung cancer risk in never-smokers

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26311

21 January 2018

Characterizing the cancer genome in lung adenocarcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26311

21 January 2018

An integrated genomic analysis of lung cancer reveals loss of DUSP4 in EGFR-mutant tumors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26311

21 January 2018

Anaplastic lymphoma kinase gene rearrangements in non-small cell lung cancer are associated with prolonged progression-free survival on pemetrexed

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26311

21 January 2018

The EML4-ALK fusion gene is involved in various histologic types of lung cancers from nonsmokers with wild-type EGFR and KRAS.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26311

21 January 2018

Reversed mutation rates of KRAS and EGFR genes in adenocarcinoma of the lung in Taiwan and their implications.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26311

21 January 2018

Advances in target therapy for lung cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26311

21 January 2018

The impact of smoking status on the behavior and survival outcome of patients with advanced non-small cell lung cancer: a retrospective analysis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26311

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q54577559&oldid=1745030901"